BASG 奥地利人用药品质量召回·· 22 小时前精选AI 评分61
BASG 公告 Pedmarqsi 80 mg/ml 输液溶液两个批次因可能含颗粒预防性召回
Pedmarqsi 80 mg/ml Infusionslösung
AI 导读
BASG 公告，分销商 Norgine Pharma GmbH 于 2026 年 10 月 19 日通知客户，Pedmarqsi 80 mg/ml 输液溶液两个批次瓶中可能存在颗粒，因此作预防性召回。
推荐理由
公告说明分销商因瓶中可能存在颗粒对两个批次作预防性召回，并列出召回分类与配送层级，便于核对批号与有效期。
正文 · 原文
Recall | Medicines | 19/10/2026
The distributor informed its customers on October 19, 2026, that there may be particles in the vials of the mentioned batches. For this reason, the mentioned batches are being recalled as a precautionary measure.
| Name of the medicinal product | Pedmarqsi 80 mg/ml Infusionslösung |
|---|---|
| Marketing authorisation number(s) | EU/1/23/1734/001 |
| CIP code | 6051949 |
| Marketing authorisation holder | Norgine B.V. |
| Distributor | Norgine Pharma GmbH |
| Batch number(s) | Batch, Expiry Date 489587, 10.2028 467504, 12.2026 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-5885 |
来源：BASG 奥地利人用药品质量召回 · basg.gv.at